Doxercalciferol - Misplaced Pages

(Redirected from Hectorol)

Doxercalciferol
Names

IUPAC name (1S,3R,5Z,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraene-1,3-diol
Other names 1-Hydroxyergocalciferol; 1-Hydroxyvitamin D2; 1α-Hydroxyergocalciferol; 1α-Hydroxyvitamin D2; Hectorol; TSA 840
Identifiers
CAS Number	54573-75-0
3D model (JSmol)	Interactive image
ChEBI	CHEBI:4712
ChEMBL	ChEMBL1200810
ChemSpider	4444554
DrugBank	DB06410
ECHA InfoCard	100.170.997
IUPHAR/BPS	2790
PubChem CID	5281107
UNII	3DIZ9LF5Y9
CompTox Dashboard (EPA)	DTXSID1034214
InChI InChI=1S/C28H44O2/c1-18(2)19(3)9-10-20(4)25-13-14-26-22(8-7-15-28(25,26)6)11-12-23-16-24(29)17-27(30)21(23)5/h9-12,18-20,24-27,29-30H,5,7-8,13-17H2,1-4,6H3/b10-9+,22-11+,23-12-/t19-,20+,24+,25+,26-,27-,28+/m0/s1Key: HKXBNHCUPKIYDM-CGMHZMFXSA-N InChI=1/C28H44O2/c1-18(2)19(3)9-10-20(4)25-13-14-26-22(8-7-15-28(25,26)6)11-12-23-16-24(29)17-27(30)21(23)5/h9-12,18-20,24-27,29-30H,5,7-8,13-17H2,1-4,6H3/b10-9+,22-11+,23-12-/t19-,20+,24+,25+,26-,27-,28+/m0/s1Key: HKXBNHCUPKIYDM-CGMHZMFXBN
SMILES O1CC(\C(=C)(O)C1)=C\C=C2/CCC3(2CC3(/C=C/(C)C(C)C)C)C
Properties
Chemical formula	C₂₈H₄₄O₂
Molar mass	412.658 g·mol
Pharmacology
ATC code	H05BX03 (WHO)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). N verify (what is ?) Infobox references

Chemical compound

Doxercalciferol (or 1-hydroxyergocalciferol, trade name Hectorol) is drug for secondary hyperparathyroidism and metabolic bone disease. It is a synthetic analog of ergocalciferol (vitamin D₂). It suppresses parathyroid synthesis and secretion.

Doxercalciferol is the vitamin D₂ analogue of alfacalcidol. It undergoes 25-hydroxylation in the liver to become the active ercalcitriol, without the involvement of kidneys.

References

Sprague S M; Ho L T (2002). "Oral doxercalciferol therapy for secondary hyperparathyroidism in a peritoneal dialysis patient". Clinical Nephrology. 58 (2): 155–160. doi:10.5414/cnp58155. PMID 12227689.
"Doxercalciferol". Drugs.com.
Upton, R. A.; Knutson, J. C.; Bishop, C. W.; LeVan, L. W. (1 April 2003). "Pharmacokinetics of doxercalciferol, a new vitamin D analogue that lowers parathyroid hormone". Nephrology Dialysis Transplantation. 18 (4): 750–758. doi:10.1093/ndt/gfg030. PMID 12637645.
"HECTOROL INJECTION (doxercalciferol)" (PDF). FDA accessdata. Retrieved 21 April 2018.

Calcium homeostasis (H05)

Parathyroid hormone and analogues

Anti-parathyroid hormone agents

Calcitonin derivatives	Calcitonin Elcatonin
Calcimimetics	Cinacalcet Etelcalcetide
Other	Calcifediol Calcitriol Cholecalciferol Cinacalcet Doxercalciferol Ergocalciferol Etelcalcetide Evocalcet Paricalcitol

v t e Vitamin D receptor modulators
VDRTooltip Vitamin D receptor	Agonists: 7-Dehydrocholesterol 25-Hydroxyergocalciferol Alfacalcidol Calcifediol Calciferol Calcipotriol Calcitriol Cholecalciferol (vitamin D₃) Dihydrotachysterol Doxercalciferol EB-1089 Eldecalcitol Ercalcidiol Ercalcitriol Ergocalciferol (vitamin D₂) Lithocholic acid Maxacalcitol Paricalcitol Tacalcitol Antagonists: ZK159222 TEI-9647
See also Receptor/signaling modulators

Vitamin D receptor modulators

VDRTooltip Vitamin D receptor

Antagonists: ZK159222
TEI-9647

See also: Receptor/signaling modulators

This hormonal preparation article is a stub. You can help Misplaced Pages by expanding it.

Categories: